liposomal daunorubicin liposomal daunorubicin liposomal daunorubicin (trade name daunoxome) is a chemotherapy drug that is fda approved to treat aids related kaposi's sarcoma. it is also commonly used to treat specific types of leukaemia and non-hodgkin lymphoma. liposomal daunorubicin is intravenously administered. it utilizes the liposomal carrier system that provides a favorable pharmacokinetic profile at the site of ks lesions resulting in a 10-fold increase in concentrations compared to that which is achieved with conventional preparations.